• Roberto Wandenkolk Vieira, President, Oncology, cut his direct stake in Corcept to 4,242 shares following Sept. 2 transactions.
• Disposed of 58,333 shares at USD 21.63 in an option exercise, then sold 58,333 shares in multiple trades at about USD 109.35 to USD 115.44.
• Also acquired 276 shares on Sept. 1, including 138 shares bought at USD 113.38.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corcept Therapeutics Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-382456), on September 03, 2026, and is solely responsible for the information contained therein.